Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleem Gangjee

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Bioorganic & Medicinal Chemistry|March 1, 2021
Potential of substituted quinazolines to interact with multiple targets in the treatment of cancerShruti Choudhary, Arpit Doshi, Lerin Luckett-Chastain, et al.
Bioorganic & Medicinal Chemistry|May 10, 2008
Design, synthesis and biological evaluation of substituted pyrrolo[2,3-d]pyrimidines as multiple receptor tyrosine kinase inhibitors and antiangiogenic agentsAleem Gangjee, Ojas A Namjoshi, Jianming Yu, et al.
Journal of Medicinal Chemistry|August 6, 2008
Synthesis and discovery of high affinity folate receptor-specific glycinamide ribonucleotide formyltransferase inhibitors with antitumor activityYijun Deng, Yiqiang Wang, Christina Cherian, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2013
Substituted pyrrolo[2,3-d]pyrimidines as Cryptosporidium hominis thymidylate synthase inhibitorsVidya P Kumar, Kathleen M Frey, Yiqiang Wang, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2021
Novel pyrazolo[4,3-d]pyrimidine microtubule targeting agents (MTAs): Synthesis, structure-activity relationship, in vitro and in vivo evaluation as antitumor agentsFarhana Islam, Tasdique M Quadery, Ruoli Bai, et al.
Bioorganic & Medicinal Chemistry|February 5, 2013
N2-Trimethylacetyl substituted and unsubstituted-N4-phenylsubstituted-6-(2-pyridin-2-ylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines: design, cellular receptor tyrosine kinase inhibitory activities and in vivo evaluation as antiangiogenic, antimetastatic and antitumor agentsAleem Gangjee, Ojas A Namjoshi, Jianming Yu, et al.
Journal of Medicinal Chemistry|February 3, 2006
Dual inhibitors of thymidylate synthase and dihydrofolate reductase as antitumor agents: design, synthesis, and biological evaluation of classical and nonclassical pyrrolo[2,3-d]pyrimidine antifolates(1)Aleem Gangjee, Hiteshkumar D Jain, Jaclyn Phan, et al.
Bioorganic & Medicinal Chemistry|June 7, 2020
Design, synthesis and biological evaluation of novel pyrrolo[2,3-d]pyrimidine as tumor-targeting agents with selectivity for tumor uptake by high affinity folate receptors over the reduced folate carrierLalit K Golani, Farhana Islam, Carrie O'Connor, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2017
Design, synthesis, and structure-activity relationships of pyrimido[4,5-b]indole-4-amines as microtubule depolymerizing agents that are effective against multidrug resistant cellsRavi Kumar Vyas Devambatla, Wei Li, Nilesh Zaware, et al.
Bioorganic & Medicinal Chemistry|April 18, 2015
The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agentsXin Zhang, Sudhir Raghavan, Michael Ihnat, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Bioorganic & Medicinal Chemistry|March 1, 2021
Potential of substituted quinazolines to interact with multiple targets in the treatment of cancerShruti Choudhary, Arpit Doshi, Lerin Luckett-Chastain, et al.
Bioorganic & Medicinal Chemistry|May 10, 2008
Design, synthesis and biological evaluation of substituted pyrrolo[2,3-d]pyrimidines as multiple receptor tyrosine kinase inhibitors and antiangiogenic agentsAleem Gangjee, Ojas A Namjoshi, Jianming Yu, et al.
Journal of Medicinal Chemistry|August 6, 2008
Synthesis and discovery of high affinity folate receptor-specific glycinamide ribonucleotide formyltransferase inhibitors with antitumor activityYijun Deng, Yiqiang Wang, Christina Cherian, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2013
Substituted pyrrolo[2,3-d]pyrimidines as Cryptosporidium hominis thymidylate synthase inhibitorsVidya P Kumar, Kathleen M Frey, Yiqiang Wang, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2021
Novel pyrazolo[4,3-d]pyrimidine microtubule targeting agents (MTAs): Synthesis, structure-activity relationship, in vitro and in vivo evaluation as antitumor agentsFarhana Islam, Tasdique M Quadery, Ruoli Bai, et al.
Bioorganic & Medicinal Chemistry|February 5, 2013
N2-Trimethylacetyl substituted and unsubstituted-N4-phenylsubstituted-6-(2-pyridin-2-ylethyl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamines: design, cellular receptor tyrosine kinase inhibitory activities and in vivo evaluation as antiangiogenic, antimetastatic and antitumor agentsAleem Gangjee, Ojas A Namjoshi, Jianming Yu, et al.
Journal of Medicinal Chemistry|February 3, 2006
Dual inhibitors of thymidylate synthase and dihydrofolate reductase as antitumor agents: design, synthesis, and biological evaluation of classical and nonclassical pyrrolo[2,3-d]pyrimidine antifolates(1)Aleem Gangjee, Hiteshkumar D Jain, Jaclyn Phan, et al.
Bioorganic & Medicinal Chemistry|June 7, 2020
Design, synthesis and biological evaluation of novel pyrrolo[2,3-d]pyrimidine as tumor-targeting agents with selectivity for tumor uptake by high affinity folate receptors over the reduced folate carrierLalit K Golani, Farhana Islam, Carrie O'Connor, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2017
Design, synthesis, and structure-activity relationships of pyrimido[4,5-b]indole-4-amines as microtubule depolymerizing agents that are effective against multidrug resistant cellsRavi Kumar Vyas Devambatla, Wei Li, Nilesh Zaware, et al.
Bioorganic & Medicinal Chemistry|April 18, 2015
The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agentsXin Zhang, Sudhir Raghavan, Michael Ihnat, et al.
Pageof 14